These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32426281)

  • 21. PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study.
    Jin L; Gu W; Li X; Xie L; Wang L; Chen Z
    Ther Adv Med Oncol; 2020; 12():1758835920962362. PubMed ID: 33062064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis.
    Yang H; Zhou X; Sun L; Mao Y
    Front Oncol; 2019; 9():47. PubMed ID: 30891423
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis.
    Piao J; Lim HJ; Lee M
    Obstet Gynecol Sci; 2020 May; 63(3):346-356. PubMed ID: 32489980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients.
    Li H; Xu Y; Wan B; Song Y; Zhan P; Hu Y; Zhang Q; Zhang F; Liu H; Li T; Sugimura H; Cappuzzo F; Lin D; Lv T;
    Transl Lung Cancer Res; 2019 Aug; 8(4):429-449. PubMed ID: 31555517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients.
    Gu X; Gao XS; Xiong W; Guo W; Han L; Bai Y; Peng C; Cui M; Xie M
    Onco Targets Ther; 2016; 9():4805-13. PubMed ID: 27536144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of different PD-L1 expression patterns and tumor-infiltrating lymphocytes in high-grade serous ovarian cancer: a systematic review and meta-analysis.
    Wang YM; Cai W; Xue QM; Zhang JY; Zhou L; Xiong SY; Deng H
    Front Immunol; 2023; 14():1234894. PubMed ID: 37654479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis.
    Yang L; Xue R; Pan C
    Onco Targets Ther; 2019; 12():3671-3682. PubMed ID: 31190869
    [No Abstract]   [Full Text] [Related]  

  • 29. The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis.
    Zhao S; Zhang M; Zhang Y; Meng H; Wang Y; Liu Y; Jing J; Huang L; Sun M; Zhang Y; Zhang Q
    Cancer Biol Med; 2018 Aug; 15(3):290-298. PubMed ID: 30197796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study.
    Wang L
    J Ovarian Res; 2019 Apr; 12(1):37. PubMed ID: 31039792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis.
    Wang Q; Liu F; Liu L
    Medicine (Baltimore); 2017 May; 96(18):e6369. PubMed ID: 28471952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients.
    Liu X; Shan C; Song Y; Du J
    Front Oncol; 2019; 9():1111. PubMed ID: 31709181
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis.
    Li X; Li M; Lian Z; Zhu H; Kong L; Wang P; Yu J
    Target Oncol; 2016 Dec; 11(6):753-761. PubMed ID: 27422273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients.
    Yang J; Dong M; Shui Y; Zhang Y; Zhang Z; Mi Y; Zuo X; Jiang L; Liu K; Liu Z; Gu X; Shi Y
    Cancer Cell Int; 2020; 20():96. PubMed ID: 32256205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis.
    Li W; Zheng Q; Luo X; Zhang X; Zheng X; Yang Y
    Transl Cancer Res; 2023 Aug; 12(8):2115-2127. PubMed ID: 37701117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis.
    Huang W; Ran R; Shao B; Li H
    Breast Cancer Res Treat; 2019 Nov; 178(1):17-33. PubMed ID: 31359214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis.
    Wang S; Yuan B; Wang Y; Li M; Liu X; Cao J; Li C; Hu J
    Int J Colorectal Dis; 2021 Jan; 36(1):117-130. PubMed ID: 32910207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological and Prognostic Value of Programmed Cell Death 1 Expression in Hepatitis B Virus-related Hepatocellular Carcinoma: A Meta-analysis.
    Zhou ZY; Liu SR; Xu LB; Liu C; Zhang R
    J Clin Transl Hepatol; 2021 Dec; 9(6):889-897. PubMed ID: 34966652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-L1 Expression in Endometrial Cancer and Its Association with Clinicopathological Features: A Systematic Review and Meta-Analysis.
    Mamat Yusof MN; Chew KT; Kampan N; Abd Aziz NH; Md Zin RR; Tan GC; Shafiee MN
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.